Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Lifestyle interventions may help pre-diabetics dodge risk of death from cardiovascular disease

Many research studies have shown that lifestyle interventions, such as exercise programmes or weight loss, in people with impaired glucose tolerance (those at high risk of diabetes) can prevent progression to overt type 2 diabetes. However, until now, there has been a lack of high quality, randomized controlled trial evidence to prove that lifestyle interventions prevent deaths from cardiovascular disease, such as heart attacks and stroke, in these people.

4 Apr 2014

MCVI receives federal approval to launch adult heart transplant program at Memorial Regional Hospital

The Memorial Cardiac and Vascular Institute (MCVI), a leading provider of adult cardiac services in South Florida, has received federal approval from UNOS (United Network for Organ Sharing) to launch an adult heart transplant program at Memorial Regional Hospital in Hollywood.

4 Apr 2014

Clinical Therapeutics features a special report on trans fat

Clinical Therapeutics features a special report in its March issue focusing on the science and policy leading up to the US Food and Drug Administration's (FDA) preliminary steps toward restricting industrially produced trans fatty acids, or trans fat, at the federal level.

3 Apr 2014

Recommended daily sodium intake harmful for health, study finds

A new study published in the American Journal of Hypertension finds evidence that the average daily sodium intake of most Americans is actually associated with better health outcomes than intake levels currently recommended by the CDC and major health departments, which are now being viewed by many in the scientific community as excessively and unrealistically low.

3 Apr 2014

Ablative Solutions’ Peregrine System Infusion Catheter receives FDA clearance

Ablative Solutions, Inc., a privately-held clinical stage company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Peregrine System(TM) Infusion Catheter.

3 Apr 2014

Managing pregnancy-related complications: an interview with Dr. Mark Zakowski

Pregnancy-related mortality has increased over the last 25 years. Ten years ago the top three pregnancy-related mortality diagnoses were hemorrhage, preeclampsia, and embolism (includes thrombotic and amniotic).

2 Apr 2014

Ablative Solutions' Peregrine System Infusion Catheter receives FDA clearance

Ablative Solutions, Inc., a privately-held clinical stage company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Peregrine System™ Infusion Catheter.

2 Apr 2014

Boston Scientific presents new data on cardiology-related clinical trials at ACC 2014

Reinforcing its position as a global leader in bringing new therapies to patients with heart and cardiovascular disease, Boston Scientific Corporation (NYSE: BSX) reported favorable results in studies related to cardiac resynchronization therapy (CRT), platinum chromium stent platforms and transcatheter aortic valve replacement (TAVR).

2 Apr 2014

Researchers develop new screening tool to help diagnose obstructive sleep apnea in children

Clinical investigators at the Children's Hospital of Eastern Ontario (CHEO) have developed a new screening tool to help diagnose obstructive sleep apnea in children. Their findings are published in Pediatric Pulmonology.

2 Apr 2014

Health Diagnostic Laboratory opens My HDL Hub health centers to prevent major chronic diseases

Health Diagnostic Laboratory, Inc. is taking the next step in its mission to detect, prevent and reverse major chronic disease such as heart disease and diabetes with the launch of My HDL Hub health centers. HDL, Inc.'s My HDL Hub is a place for individuals to receive comprehensive blood tests, gain lifestyle, nutrition and fitness guidance with the company's Clinical Health Consultants and relate to others in the community with common goals of becoming healthier.

1 Apr 2014

People with low and very high levels of transferrin saturation ratio are at increased risk of death

A new study led by researchers at the Graduate Entry Medical School, University of Limerick has found that people with low levels and very high levels of a commonly measured laboratory test, the “transferrin saturation ratio” are at an increased risk of death. The test is a measure of the amount of available iron in the bloodstream with low levels generally reflecting a state of iron deficiency and high levels suggesting a relative excess.

1 Apr 2014

Research uncovers link between diet and blood cell markers of heart attack associated inflammation

New research further illuminates the heart-healthy benefits of the Mediterranean diet, tying the eating plan to lower levels of platelets and white blood cells, two markers of inflammation. Inflammation has an association with greater risk of heart attack and stroke.

1 Apr 2014

Study shows administering steroids during cardiac surgery requiring bypass can cause harm

Giving patients steroids at the time of heart surgery does not improve health outcomes and appears to put them at greater risk of having a heart attack in the days following surgery, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session.

1 Apr 2014

Men with long-term HIV infections at higher risk of developing plaque in their coronary arteries

Men with long-term HIV infections are at higher risk than uninfected men of developing plaque in their coronary arteries, regardless of their other risk factors for coronary artery disease, according to results of a study led by Johns Hopkins researchers. A report on the research appears in the April 1 issue of Annals of Internal Medicine.

1 Apr 2014

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Amgen (NASDAQ: AMGN) today announced new detailed data from three Phase 3 studies that showed treatment with its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), resulted in a statistically significant reduction of 55-66 percent in low-density lipoprotein cholesterol (LDL-C) compared to placebo in patients with high cholesterol.

31 Mar 2014

Researchers quantify proportion of adults potentially affected by updated 2014 BP recommendations

Applying the updated 2014 blood pressure (BP) guideline to the U.S. population suggests that nearly 6 million adults are no longer classified as needing hypertension medication, and that an estimated 13.5 million adults would now be considered as having achieved goal blood pressure, primarily older adults, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions.

31 Mar 2014

Newly identified protein markers have potential to contribute to better understanding of heart disease

Researchers at the Intermountain Medical Center Heart Institute in Murray, Utah, have discovered that elevated levels of two recently identified proteins in the body are inflammatory markers and indicators of the presence of cardiovascular disease.

31 Mar 2014

Study on effects of cholesterol-lowering medications on sexual health

A new study is giving hope to older men who are concerned about the effects of cholesterol-lowering medications on their sexual health.

31 Mar 2014

Aleglitazar drug does not reduce risk of cardiovascular events in patients with type 2 diabetes

Use of the drug aleglitazar, which has shown the ability to lower glucose levels and have favorable effects on cholesterol, did not reduce the risk of cardiovascular death, heart attack or stroke among patients with type 2 diabetes and recent heart attack or unstable angina, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions.

31 Mar 2014

Women who drink too many diet drinks a day more likely to have heart problems

It appears healthy postmenopausal women who drink two or more diet drinks a day may be more likely to have a heart attack, stroke or other cardiovascular problems, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.

31 Mar 2014

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Lifestyle interventions may help pre-diabetics dodge risk of death from cardiovascular disease

MCVI receives federal approval to launch adult heart transplant program at Memorial Regional Hospital

Clinical Therapeutics features a special report on trans fat

Recommended daily sodium intake harmful for health, study finds

Ablative Solutions’ Peregrine System Infusion Catheter receives FDA clearance

Managing pregnancy-related complications: an interview with Dr. Mark Zakowski

Ablative Solutions' Peregrine System Infusion Catheter receives FDA clearance

Boston Scientific presents new data on cardiology-related clinical trials at ACC 2014

Researchers develop new screening tool to help diagnose obstructive sleep apnea in children

Health Diagnostic Laboratory opens My HDL Hub health centers to prevent major chronic diseases

People with low and very high levels of transferrin saturation ratio are at increased risk of death

Research uncovers link between diet and blood cell markers of heart attack associated inflammation

Study shows administering steroids during cardiac surgery requiring bypass can cause harm

Men with long-term HIV infections at higher risk of developing plaque in their coronary arteries

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Researchers quantify proportion of adults potentially affected by updated 2014 BP recommendations

Newly identified protein markers have potential to contribute to better understanding of heart disease

Study on effects of cholesterol-lowering medications on sexual health

Aleglitazar drug does not reduce risk of cardiovascular events in patients with type 2 diabetes

Women who drink too many diet drinks a day more likely to have heart problems

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in